137 related articles for article (PubMed ID: 26783083)
21. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
[TBL] [Abstract][Full Text] [Related]
22. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.
Becker J; May A; Gerges C; Anders M; Veits L; Weise K; Czamara D; Lyros O; Manner H; Terheggen G; Venerito M; Noder T; Mayershofer R; Hofer JH; Karch HW; Ahlbrand CJ; Arras M; Hofer S; Mangold E; Heilmann-Heimbach S; Heinrichs SK; Hess T; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Müller-Myhsok B; Ott K; Schmidt T; Whiteman DC; Vaughan TL; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
Cancer Med; 2015 Nov; 4(11):1700-4. PubMed ID: 26383589
[TBL] [Abstract][Full Text] [Related]
23. Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
Stachler MD; Camarda ND; Deitrick C; Kim A; Agoston AT; Odze RD; Hornick JL; Nag A; Thorner AR; Ducar M; Noffsinger A; Lash RH; Redston M; Carter SL; Davison JM; Bass AJ
Gastroenterology; 2018 Jul; 155(1):156-167. PubMed ID: 29608884
[TBL] [Abstract][Full Text] [Related]
24. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.
Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J
Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052
[TBL] [Abstract][Full Text] [Related]
26. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
27. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
29. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ
Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
[TBL] [Abstract][Full Text] [Related]
30. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
[TBL] [Abstract][Full Text] [Related]
31. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
[TBL] [Abstract][Full Text] [Related]
32. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
33. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.
Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB
Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528
[TBL] [Abstract][Full Text] [Related]
34. Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.
Chen J; Ali MW; Yan L; Dighe SG; Dai JY; Vaughan TL; Casey G; Buas MF
Hum Mol Genet; 2022 Feb; 31(3):410-422. PubMed ID: 34505128
[TBL] [Abstract][Full Text] [Related]
35. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CD55 from Barrett's esophagus is associated with esophageal adenocarcinoma risk.
Murao T; Shiotani A; Fujita Y; Yamanaka Y; Kamada T; Manabe N; Hata J; Nishio K; Haruma K
J Gastroenterol Hepatol; 2016 Jan; 31(1):99-106. PubMed ID: 26202380
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis.
Wang S; Zhan M; Yin J; Abraham JM; Mori Y; Sato F; Xu Y; Olaru A; Berki AT; Li H; Schulmann K; Kan T; Hamilton JP; Paun B; Yu MM; Jin Z; Cheng Y; Ito T; Mantzur C; Greenwald BD; Meltzer SJ
Oncogene; 2006 Jun; 25(23):3346-56. PubMed ID: 16449976
[TBL] [Abstract][Full Text] [Related]
38. Identification of loci of functional relevance to Barrett's esophagus and esophageal adenocarcinoma: Cross-referencing of expression quantitative trait loci data from disease-relevant tissues with genetic association data.
Schröder J; Schüller V; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Ludwig KU; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dakkak D; Jansen-Winkeln B; Moulla Y; Lyros O; Niebisch S; Mehdorn M; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Mangold E; Nöthen MM; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J; Böhmer AC
PLoS One; 2019; 14(12):e0227072. PubMed ID: 31891614
[TBL] [Abstract][Full Text] [Related]
39. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma risk.
Wanchai V; Jin J; Bircan E; Eng C; Orloff M
BMC Bioinformatics; 2019 Mar; 20(Suppl 2):98. PubMed ID: 30871476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
